피라진아마이드 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "피라진아마이드" in Korean language version.

refsWebsite

Global rank Korean rank

7nih.gov

4^th place

6doi.org

2^nd place

3^rd place

1ingenta.com

low place

1nature.com

234^th place

148^th place

1web.archive.org

1^st place

1atsjournals.org

low place

atsjournals.org

ajrccm.atsjournals.org

Yee D; 외. (2003년). “Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis”. 《Am J Resp Crit Care Med》 167 (11): 1472~7. doi:10.1164/rccm.200206-626OC. PMID 12569078. 2006년 2월 12일에 원본 문서에서 보존된 문서. 2011년 2월 6일에 확인함.

doi.org

dx.doi.org

Hong Kong Chest Service, Medical Research Council (1981년). “Controlled trial of four thrice weekly regimens and a daily regimen given for 6 months for pulmonary tuberculosis”. 《Lancet》 1 (8213): 171~4. doi:10.1016/S0140-6736(02)95623-0. PMID 6109855.
Zimhony O, Cox JS, Welch JT, Vilchèze C, Jacobs WR (2000년). “Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of Mycobacterium tuberculosis” (abstract). 《Nature Medicine》 6 (9): 1043~47. doi:10.1038/79558. PMID 10973326. CS1 관리 - 여러 이름 (링크)
Boshoff HI, Mizrahi V, Barry CE (2002년). “Effects of Pyrazinamide on Fatty Acid Synthesis by Whole Mycobacterial Cells and Purified Fatty Acid Synthase I”. 《Journal of Bacteriology》 184 (8): 2167~72. doi:10.1128/JB.184.8.2167-2172.2002. PMC 134955. PMID 11914348. CS1 관리 - 여러 이름 (링크)
East and Central African/Medical Research Council Fifth Collaborative Study (1983년). “Controlled clinical trial of 4 short-course regimens of chemotherapy (three 6-month and one 9-month) for pulmonary tuberculosis”. 《Tubercle》 64 (3): 153~166. doi:10.1016/0041-3879(83)90011-9. PMID 6356538.
British Thoracic Society (1984). “A controlled trial of 6 months chemotherapy in pulmonary tuberculosis, final report: results during the 36 months after the end of chemotherapy and beyond”. 《Br J Dis Chest》 78 (4): 330~336. doi:10.1016/0007-0971(84)90165-7. PMID 6386028.
Yee D; 외. (2003년). “Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis”. 《Am J Resp Crit Care Med》 167 (11): 1472~7. doi:10.1164/rccm.200206-626OC. PMID 12569078. 2006년 2월 12일에 원본 문서에서 보존된 문서. 2011년 2월 6일에 확인함.

ingenta.com

openurl.ingenta.com

Zhang Y, Mitchison D (2003년 1월). “The curious characteristics of pyrazinamide: a review”. 《Int. J. Tuberc. Lung Dis.》 7 (1): 6–21. PMID 12701830.

nature.com

Zimhony O, Cox JS, Welch JT, Vilchèze C, Jacobs WR (2000년). “Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of Mycobacterium tuberculosis” (abstract). 《Nature Medicine》 6 (9): 1043~47. doi:10.1038/79558. PMID 10973326. CS1 관리 - 여러 이름 (링크)

nih.gov

ncbi.nlm.nih.gov

Hong Kong Chest Service, Medical Research Council (1981년). “Controlled trial of four thrice weekly regimens and a daily regimen given for 6 months for pulmonary tuberculosis”. 《Lancet》 1 (8213): 171~4. doi:10.1016/S0140-6736(02)95623-0. PMID 6109855.
Zhang Y, Mitchison D (2003년 1월). “The curious characteristics of pyrazinamide: a review”. 《Int. J. Tuberc. Lung Dis.》 7 (1): 6–21. PMID 12701830.
Zimhony O, Cox JS, Welch JT, Vilchèze C, Jacobs WR (2000년). “Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of Mycobacterium tuberculosis” (abstract). 《Nature Medicine》 6 (9): 1043~47. doi:10.1038/79558. PMID 10973326. CS1 관리 - 여러 이름 (링크)
Boshoff HI, Mizrahi V, Barry CE (2002년). “Effects of Pyrazinamide on Fatty Acid Synthesis by Whole Mycobacterial Cells and Purified Fatty Acid Synthase I”. 《Journal of Bacteriology》 184 (8): 2167~72. doi:10.1128/JB.184.8.2167-2172.2002. PMC 134955. PMID 11914348. CS1 관리 - 여러 이름 (링크)
East and Central African/Medical Research Council Fifth Collaborative Study (1983년). “Controlled clinical trial of 4 short-course regimens of chemotherapy (three 6-month and one 9-month) for pulmonary tuberculosis”. 《Tubercle》 64 (3): 153~166. doi:10.1016/0041-3879(83)90011-9. PMID 6356538.
British Thoracic Society (1984). “A controlled trial of 6 months chemotherapy in pulmonary tuberculosis, final report: results during the 36 months after the end of chemotherapy and beyond”. 《Br J Dis Chest》 78 (4): 330~336. doi:10.1016/0007-0971(84)90165-7. PMID 6386028.
Yee D; 외. (2003년). “Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis”. 《Am J Resp Crit Care Med》 167 (11): 1472~7. doi:10.1164/rccm.200206-626OC. PMID 12569078. 2006년 2월 12일에 원본 문서에서 보존된 문서. 2011년 2월 6일에 확인함.

web.archive.org

Yee D; 외. (2003년). “Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis”. 《Am J Resp Crit Care Med》 167 (11): 1472~7. doi:10.1164/rccm.200206-626OC. PMID 12569078. 2006년 2월 12일에 원본 문서에서 보존된 문서. 2011년 2월 6일에 확인함.